HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Aude Ambresin Selected Research

Macular Edema

1/2021Persistent Remnants of Dexamethasone Intravitreal Implant Over 24 Months in a Patient Suffering from Anterior and Intermediate Uveitis Associated with Macular Edema.
4/2020Optical Coherence Tomography Analysis of Cystoid Macular Edema in Retinal Dystrophy Treated with Oral Acetazolamide: Two Cases.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Aude Ambresin Research Topics

Disease

13Macular Degeneration (Age-Related Maculopathy)
11/2017 - 01/2007
3Choroidal Neovascularization
11/2010 - 03/2009
2Inflammation (Inflammations)
04/2022 - 01/2014
2Macular Edema
01/2021 - 04/2020
2Telangiectasis (Telangiectasia)
12/2017 - 07/2016
2Hemorrhage
12/2015 - 11/2011
1COVID-19
04/2022
1Epiretinal Membrane (Epiretinal Membranes)
01/2021
1Intermediate Uveitis (Chronic Cyclitis)
01/2021
1Night Blindness (Nyctalopia)
01/2021
1Retinal Dystrophies
04/2020
1Weight Loss (Weight Reduction)
01/2020
1Retinal Neovascularization
04/2019
1Retinal Vein Occlusion
02/2018
1Pain (Aches)
01/2018
1Ischemia
12/2015
1Ischemic Optic Neuropathy (Anterior Ischemic Optic Neuropathy)
12/2015
1Arterial Occlusive Diseases (Arterial Occlusive Disease)
12/2015
1Endophthalmitis (Ophthalmia)
01/2014
1Cysts
03/2013
1Fibrosis (Cirrhosis)
11/2011
1Atrophy
11/2011
1Central Serous Chorioretinopathy
09/2010
1Eye Diseases (Eye Disease)
01/2010
1Idiopathic Juxtafoveal Retinal Telangiectasia
11/2009
1Myopia
03/2009
1Cone-Rod Dystrophies
02/2009
1Jalili syndrome
02/2009
1Retinal Perforations
10/2003
1Hyphema
06/2002
1Choroidal Effusions
06/2002
1Glaucoma
06/2002

Drug/Important Bio-Agent (IBA)

11Ranibizumab (Lucentis)FDA Link
05/2016 - 01/2008
7Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
02/2018 - 01/2007
4Retinaldehyde (Retinal)IBA
04/2022 - 10/2003
4afliberceptIBA
12/2017 - 10/2015
2Fluorescein (Funduscein)FDA LinkGeneric
04/2022 - 07/2016
2Proteins (Proteins, Gene)FDA Link
01/2020 - 02/2009
2Pharmaceutical PreparationsIBA
05/2016 - 10/2015
1Dexamethasone (Maxidex)FDA LinkGeneric
01/2021
1Vitamin A (Retinol)FDA LinkGeneric
01/2021
1Acetazolamide (Diamox)FDA LinkGeneric
04/2020
1Adalimumab (Humira)FDA Link
04/2019
1Adrenal Cortex Hormones (Corticosteroids)IBA
04/2019
1Complement System Proteins (Complement)IBA
03/2014
1Complement Factor B (Factor B)IBA
03/2014
1Anti-Bacterial Agents (Antibiotics)IBA
01/2014
1Retinal Pigments (Pigments, Visual)IBA
11/2011
1Endothelial Growth FactorsIBA
01/2010
1MetalsIBA
02/2009
1CollagenIBA
06/2002

Therapy/Procedure

6Intravitreal Injections
01/2018 - 03/2009
2Vitrectomy
01/2021 - 10/2003
2Therapeutics
02/2018 - 01/2010
2Retreatment
11/2017 - 03/2013
1Gastric Bypass (Roux-en-Y Gastric Bypass)
01/2020
1Injections
01/2007
1Light Coagulation
10/2003
1Trabeculectomy (Trabeculoplasty)
06/2002